CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$4.1M	791K	+41,250	+5.5%	$5.19	Q3 2024
6/30/2024	0%	+0%	$1.93M	750K	+49,537	+7.08%	$2.57	Q2 2024
3/31/2024	0%	+0%	$3.44M	700K	+22,686	+3.35%	$4.92	Q1 2024
12/31/2023	0%	+0%	$5.95M	677K	+13,826	+2.08%	$8.79	Q4 2023
9/30/2023	0%	+0%	$7.61M	664K	+36,493	+5.82%	$11.47	Q3 2023
6/30/2023	0%	+0%	$15.9M	627K	+19,710	+3.25%	$25.31	Q2 2023
3/31/2023	0.01%	+0%	$19.6M	607K	+717	+0.12%	$32.21	Q1 2023
12/31/2022	0%	+0%	$11.2M	607K	+38,059	+6.69%	$18.46	Q4 2022
9/30/2022	0.01%	+0%	$15.4M	569K	+86,844	+18%	$27.00	Q3 2022
6/30/2022	0%	0%	$6.66M	482K	-9,747	-1.98%	$13.82	Q2 2022
3/31/2022	0%	+0%	$9.58M	491K	+14,638	+3.07%	$19.50	Q1 2022
12/31/2021	0%	+0%	$7.78M	477K	+5,557	+1.18%	$16.32	Q4 2021
9/30/2021	0%	+0%	$13.1M	471K	+3,056	+0.65%	$27.86	Q3 2021
6/30/2021	0%	+0%	$13.9M	468K	+21,270	+4.76%	$29.64	Q2 2021
3/31/2021	0%	+0%	$12.5M	447K	+35,910	+8.74%	$27.95	Q1 2021
12/31/2020	0%	+0%	$11.6M	411K	+5,169	+1.27%	$28.34	Q4 2020
9/30/2020	0%	+0%	$10.2M	406K	+69,842	+20.8%	$25.14	Q3 2020
6/30/2020	0%	+0%	$8.21M	336K	+30,846	+10.1%	$24.42	Q2 2020
3/31/2020	0%	+0%	$4.52M	305K	+35,815	+13.3%	$14.80	Q1 2020
12/31/2019	0%	+0%	$4.37M	269K	+24,274	+9.9%	$16.23	Q4 2019
9/30/2019	0%	+0%	$3.19M	245K	+2,321	+0.96%	$13.00	Q3 2019
6/30/2019	0%	+0%	$3.15M	243K	+17,383	+7.71%	$12.97	Q2 2019
3/31/2019	0%	+0%	$3.55M	225K	+48,353	+27.3%	$15.76	Q1 2019
12/31/2018	0%	0%	$3.56M	177K	-898	-0.5%	$20.13	Q4 2018
9/30/2018	0%	+0%	$4.42M	178K	+25,131	+16.4%	$24.85	Q3 2018
6/30/2018	0%	+0%	$4.2M	153K	+18,179	+13.5%	$27.46	Q2 2018
3/31/2018	0%	+0%	$4.15M	135K	+16,307	+13.8%	$30.81	Q1 2018
12/31/2017	0%	+0%	$4.23M	118K	+1,051	+0.9%	$35.75	Q4 2017
9/30/2017	0%	+0%	$3.23M	117K	+5,501	+4.92%	$27.55	Q3 2017
6/30/2017	0%	+0%	$2.95M	112K	+19,267	+20.8%	$26.41	Q2 2017
3/31/2017	0%	+0%	$1.92M	92.5K	+3,933	+4.44%	$20.80	Q1 2017
12/31/2016	0%	+0%	$1.83M	88.6K	+28,842	+48.3%	$20.71	Q4 2016
9/30/2016	0%	0%	$968K	59.7K	-6,548	-9.88%	$16.21	Q3 2016
6/30/2016	0%	+0%	$902K	66.3K	+1,320	+2.03%	$13.61	Q2 2016
3/31/2016	0%	+0%	$1.13M	64.9K	+1,476	+2.33%	$17.46	Q1 2016
12/31/2015	0%	+0%	$2.17M	63.5K	+16,625	+35.5%	$34.18	Q4 2015
9/30/2015	0%	+0%	$1.4M	46.8K	+10,608	+29.3%	$29.78	Q3 2015
6/30/2015	0%	+0%	$1.16M	36.2K	+9,561	+35.8%	$31.99	Q2 2015
3/31/2015	0%	+0%	$553K	26.7K	+1,508	+5.99%	$20.73	Q1 2015
12/31/2014	0%	+0%	$427K	25.2K	+5,918	+30.7%	$16.97	Q4 2014
9/30/2014	0%	+0%	$373K	19.2K	+3,819	+24.8%	$19.38	Q3 2014
6/30/2014	0%	+0%	$525K	15.4K	+15,428	NEW	$34.03	Q2 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.